BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun H, Yu T, Li X, Lei Y, Li J, Wang X, Peng P, Ni D, Wang X, Luo Y. Second near-infrared photothermal-amplified immunotherapy using photoactivatable composite nanostimulators. J Nanobiotechnology 2021;19:433. [PMID: 34930269 DOI: 10.1186/s12951-021-01197-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Shang H, Wu J, Liu X, Tong Y, He Y, Huang Q, Xia D, Peng E, Chen Z, Tang K. Second near-infrared nanomaterials for cancer photothermal immunotherapy. Materials Today Advances 2023;17:100339. [DOI: 10.1016/j.mtadv.2022.100339] [Reference Citation Analysis]
2 Zhang Q, Xu X, Yang Q, Duan Y, Chen C, Zhao S, Ouyang Y, Chen Y, Cao Y, Liu H. Mesoporous polydopamine-based nanoplatform for enhanced tumor chemodynamic therapy through the reducibility weakening strategy. Colloids Surf B Biointerfaces 2023;222:113091. [PMID: 36542951 DOI: 10.1016/j.colsurfb.2022.113091] [Reference Citation Analysis]
3 Qian Y, Wang J, Bu W, Zhu X, Zhang P, Zhu Y, Fan X, Wang C. Targeted implementation strategies of precise photodynamic therapy based on clinical and technical demands. Biomater Sci 2023;11:704-18. [PMID: 36472233 DOI: 10.1039/d2bm01384c] [Reference Citation Analysis]
4 Yang L, Gai S, Ding H, Yang D, Feng L, Yang P. Recent Progress in Inorganic Afterglow Materials: Mechanisms, Persistent Luminescent Properties, Modulating Methods, and Bioimaging Applications. Advanced Optical Materials 2023. [DOI: 10.1002/adom.202202382] [Reference Citation Analysis]
5 Zhang J, Huang L, Ge G, Hu K. Emerging Epigenetic-Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment. Adv Sci (Weinh) 2023;:e2206169. [PMID: 36599655 DOI: 10.1002/advs.202206169] [Reference Citation Analysis]
6 Mao H, Wen Y, Yu Y, Li H, Wang J, Sun B. Ignored role of polyphenol in boosting reactive oxygen species generation for polyphenol/chemodynamic combination therapy. Mater Today Bio 2022;16:100436. [PMID: 36176720 DOI: 10.1016/j.mtbio.2022.100436] [Reference Citation Analysis]
7 Shen J, Lin M, Ding M, Yu N, Yang C, Kong D, Sun H, Xie Z. Tumor immunosuppressive microenvironment modulating hydrogels for second near-infrared photothermal-immunotherapy of cancer. Mater Today Bio 2022;16:100416. [PMID: 36105677 DOI: 10.1016/j.mtbio.2022.100416] [Reference Citation Analysis]
8 Xiao M, Shi Y, Jiang S, Cao M, Chen W, Xu Y, Xu Z, Wang K. Recent advances of nanomaterial-based anti-angiogenic therapy in tumor vascular normalization and immunotherapy. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1039378] [Reference Citation Analysis]
9 Fang D, Liu Z, Jin H, Huang X, Shi Y, Ben S. Manganese-Based Prussian Blue Nanocatalysts Suppress Non-Small Cell Lung Cancer Growth and Metastasis via Photothermal and Chemodynamic Therapy. Front Bioeng Biotechnol 2022;10:939158. [DOI: 10.3389/fbioe.2022.939158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Trucillo P. Drug Carriers: A Review on the Most Used Mathematical Models for Drug Release. Processes 2022;10:1094. [DOI: 10.3390/pr10061094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wang F, Zhu J, Wang Y, Li J. Recent Advances in Engineering Nanomedicines for Second Near-Infrared Photothermal-Combinational Immunotherapy. Nanomaterials 2022;12:1656. [DOI: 10.3390/nano12101656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Heshmati Aghda N, Dabbaghianamiri M, Tunnell JW, Betancourt T. Design of Smart Nanomedicines for Effective Cancer Treatment. Int J Pharm 2022;:121791. [PMID: 35525473 DOI: 10.1016/j.ijpharm.2022.121791] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Zhou B, Liu J, Wang L, Wang M, Zhao C, Lin H, Liang Y, Towner RA, Chen WR. Iron oxide nanoparticles as a drug carrier reduce host immunosuppression for enhanced chemotherapy. Nanoscale 2022;14:4588-94. [PMID: 35253815 DOI: 10.1039/d1nr07750c] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]